Rutgers Cancer Institute
@rutgerscancer
Rutgers Cancer Institute is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.
ID: 2802993134
http://cinj.org/ 11-09-2014 04:16:49
7,7K Tweet
4,4K Followers
1,1K Following
Know the Why. Dr. Ronald Ennis, Medical Director, Clinical Network for Radiation Oncology at Rutgers Cancer Institute, and Dr. Malay Rao, Radiation Oncologist at CBMC, share important information about #PLUVICTO. #LetsBeatCancerTogether #cancertreatment #radiationoncology #cancer
Important to determine risk factors for infections when using bispecific antibodies for myeloma. glad to be part of this collaborative effort! #myeloma #mmsm Rutgers Cancer Institute
Watch Bladder Cancer Advocacy Network's webinar on Enhancing Bladder Cancer Surgery Recover: Strategies for Better Patient Outcomes featuring Rutgers Cancer Institute & RWJBarnabas' expert Dr. Saum Ghodoussipour Saum Ghodoussipour. bcan.org/enhancing-blad… #BladderCancer #Bladder #BladderSurgery #Cancer
NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas cinj.org/clinical-trial…
.Rutgers Cancer Institute & RWJBarnabas's Toni Beninato MD & Dr. Amanda Laird's paper "Reoperation Rates After Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study" is the subject in Medscape article medscape.com/viewarticle/lo… @rwjms Rutgers Research Marin Kheng, MD MPH
NOW OPEN Rutgers Cancer Institute: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” Christian Hinrichs #ClinicalTrial #CancerResearch RWJBarnabas cinj.org/clinical-trial…
September is a crucial month for awareness. Rutgers Cancer Institute & RWJBarnabas our experts provide state-of-the-art, compassionate care for #ProstateCancer, gynecologic cancer, childhood cancer, blood cancer, #ThyroidCancer, sickle cell disease & other cancers. cinj.org/patient-care/p…
Program Spotlight ⭐ Rutgers Cancer Institute, our team of experts who specialize in #leukemia, #lymphoma & other hematologic malignancies combine expertise in clinical care & translational research to provide exceptional, personalized, & compassionate care. ow.ly/gxUM50SQlQq
Rutgers Cancer Institute: “A Phase 1b Study Evaluating the Safety & Efficacy of First-Line Tarlatamab in Combination With Carboplatin, Etoposide, & PD-L1 Inhibitor in Subjects with Extensive Stage Small Cell Lung Cancer.” RWJBarnabas Missak Haigentz #LCSM cinj.org/clinical-trial…
Prostate cancer is a common health concern for men. As they age, risk increases, so it's important to be aware of the signs and symptoms. Dr. David M. Golombos, urologic oncologist Rutgers Cancer Institute and RWJBarnabas Health, shares what men need to know: rwjbh.org/blog/2024/augu…
Listen to Big Ten Cancer Research Consortium's podcast episode "Patient perspective: A Black woman's personal experience regarding clinical trial treatment" with Rutgers Cancer Institute RWJBarnabas #BreastCancer expert Dr. Coral Omene Coral Omene, MD, PhD.
.Rutgers Cancer Institute RWJBarnabas Health, have appointed Dr. Jonathan Sherman Jonathan H Sherman, MD, as chief of Neurosurgical Oncology Rutgers Cancer Institute. He is also a professor in the Department of Neurological Surgery at Rutgers RWJMedSchool. Welcome Dr. Sherman! Robert Wood Johnson University Hospital cinj.org/jonathan-h-she…
.Rutgers Cancer Institute is hiring an Associate Director for Education & Training. Lead cutting-edge cancer research education initiatives, collaborate with top institutions, and shape the future of oncology training. jobs.rutgers.edu/postings/230717 RWJBarnabas #CancerResearch #Leadership #CRTEC
Prostate cancer is a common health concern for men. Dr. David M. Golombos, urologic oncologist at Rutgers Cancer Institute and RWJBarnabas, shares what men need to know: rwjbh.org/blog/2024/augu… #LetsBeatCancerTogether #WellnessWednesday #LetsBeHealthyTogether rwjbh.org/hamilton
Rutgers Cancer Institute NOW OPEN: “A Phase 3, Randomized Study Evaluating the Efficacy & Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder...” cinj.org/clinical-trial…
Did you know that #MultipleMyeloma is a #bloodcancer that begins in plasma cells (white blood cells that produce antibodies)? Some features include low blood counts (such as anemia), bone & calcium problems, infections & kidney problems. cinj.org/MultipleMyeloma RWJBarnabas
Join Rutgers Cancer Institute RWJBarnabas for a virtual town hall on 9/27 at 4pm in recognition of #BreastCancerAwarenessMonth in Oct. Learn about #clinicaltrials and speak to experts Dr. Coral Omene Coral Omene, MD, PhD & Dr. Maria Kowzun Maria Kowzun with Ms. Dorothy Reed.go.rutgers.edu/f1er6l4v